122 related articles for article (PubMed ID: 1611305)
21. Thyroid hormone enhances aggrecanase-2/ADAM-TS5 expression and proteoglycan degradation in growth plate cartilage.
Makihira S; Yan W; Murakami H; Furukawa M; Kawai T; Nikawa H; Yoshida E; Hamada T; Okada Y; Kato Y
Endocrinology; 2003 Jun; 144(6):2480-8. PubMed ID: 12746310
[TBL] [Abstract][Full Text] [Related]
22. Sex-dependent effects of 17-beta-estradiol on chondrocyte differentiation in culture.
Nasatzky E; Schwartz Z; Boyan BD; Soskolne WA; Ornoy A
J Cell Physiol; 1993 Feb; 154(2):359-67. PubMed ID: 8425917
[TBL] [Abstract][Full Text] [Related]
23. Fibronectin fragments induce the expression of stromelysin-1 mRNA and protein in bovine chondrocytes in monolayer culture.
Bewsey KE; Wen C; Purple C; Homandberg GA
Biochim Biophys Acta; 1996 Oct; 1317(1):55-64. PubMed ID: 8876627
[TBL] [Abstract][Full Text] [Related]
24. Effects of X irradiation on metabolism of proteoglycans.
Jikko A; Hiranuma H; Iwamoto M; Kato Y; Okada Y; Fuchihata H
Radiat Res; 1996 Jul; 146(1):93-9. PubMed ID: 8677304
[TBL] [Abstract][Full Text] [Related]
25. Secretion of matrix metalloproteinase-2 (72 kD gelatinase/type IV collagenase = gelatinase A) by malignant human glioma cell lines: implications for the growth and cellular invasion of the extracellular matrix.
Nakagawa T; Kubota T; Kabuto M; Fujimoto N; Okada Y
J Neurooncol; 1996 Apr; 28(1):13-24. PubMed ID: 8740587
[TBL] [Abstract][Full Text] [Related]
26. The regulation of MMPs and TIMPs in cartilage turnover.
Cawston T; Billington C; Cleaver C; Elliott S; Hui W; Koshy P; Shingleton B; Rowan A
Ann N Y Acad Sci; 1999 Jun; 878():120-9. PubMed ID: 10415724
[TBL] [Abstract][Full Text] [Related]
27. The first stage of transforming growth factor beta1 activation is release of the large latent complex from the extracellular matrix of growth plate chondrocytes by matrix vesicle stromelysin-1 (MMP-3).
Maeda S; Dean DD; Gomez R; Schwartz Z; Boyan BD
Calcif Tissue Int; 2002 Jan; 70(1):54-65. PubMed ID: 11907708
[TBL] [Abstract][Full Text] [Related]
28. Lactate dehydrogenase isoenzymes in matrix vesicles (review).
Hosokawa R; Ohashi-Takeuchi H; Yamada N; Uchida Y; Fujiwara S; Noguchi T
Bone Miner; 1992 May; 17(2):177-81. PubMed ID: 1611306
[TBL] [Abstract][Full Text] [Related]
29. The effects of cytokines on metalloproteinase inhibitors (TIMP) and collagenase production by human chondrocytes and TIMP production by synovial cells and endothelial cells.
Shingu M; Nagai Y; Isayama T; Naono T; Nobunaga M; Nagai Y
Clin Exp Immunol; 1993 Oct; 94(1):145-9. PubMed ID: 8403497
[TBL] [Abstract][Full Text] [Related]
30. Nongenomic regulation of chondrocyte membrane fluidity by 1,25-(OH)2D3 and 24,25-(OH)2D3 is dependent on cell maturation.
Swain LD; Schwartz Z; Caulfield K; Brooks BP; Boyan BD
Bone; 1993; 14(4):609-17. PubMed ID: 8274303
[TBL] [Abstract][Full Text] [Related]
31. Effect of 17 beta-estradiol on chondrocyte membrane fluidity and phospholipid metabolism is membrane-specific, sex-specific, and cell maturation-dependent.
Schwartz Z; Gates PA; Nasatzky E; Sylvia VL; Mendez J; Dean DD; Boyan BD
Biochim Biophys Acta; 1996 Jun; 1282(1):1-10. PubMed ID: 8679644
[TBL] [Abstract][Full Text] [Related]
32. Direct effects of transforming growth factor-beta on chondrocytes are modulated by vitamin D metabolites in a cell maturation-specific manner.
Schwartz Z; Bonewald LF; Caulfield K; Brooks B; Boyan BD
Endocrinology; 1993 Apr; 132(4):1544-52. PubMed ID: 8462452
[TBL] [Abstract][Full Text] [Related]
33. Immunolocalization of matrix metalloproteinases in partial-thickness defects in pig articular cartilage. A preliminary report.
Hembry RM; Dyce J; Driesang I; Hunziker EB; Fosang AJ; Tyler JA; Murphy G
J Bone Joint Surg Am; 2001 Jun; 83(6):826-38. PubMed ID: 11407790
[TBL] [Abstract][Full Text] [Related]
34. Treatment of resting zone chondrocytes with 24,25-dihydroxyvitamin D3 [24,25-(OH)2D3] induces differentiation into a 1,25-(OH)2D3-responsive phenotype characteristic of growth zone chondrocytes.
Schwartz Z; Dean DD; Walton JK; Brooks BP; Boyan BD
Endocrinology; 1995 Feb; 136(2):402-11. PubMed ID: 7530645
[TBL] [Abstract][Full Text] [Related]
35. Control of extracellular matrix homeostasis of normal cartilage by a TGFbeta autocrine pathway. Validation of flow cytometry as a tool to study chondrocyte metabolism in vitro.
Wang L; Almqvist KF; Veys EM; Verbruggen G
Osteoarthritis Cartilage; 2002 Mar; 10(3):188-98. PubMed ID: 11869079
[TBL] [Abstract][Full Text] [Related]
36. Cell maturation-specific autocrine/paracrine regulation of matrix vesicles.
Boyan BD; Schwartz Z; Swain LD
Bone Miner; 1992 May; 17(2):263-8. PubMed ID: 1611318
[TBL] [Abstract][Full Text] [Related]
37. Localization of matrix metalloproteinase 3 (stromelysin) in osteoarthritic cartilage and synovium.
Okada Y; Shinmei M; Tanaka O; Naka K; Kimura A; Nakanishi I; Bayliss MT; Iwata K; Nagase H
Lab Invest; 1992 Jun; 66(6):680-90. PubMed ID: 1602738
[TBL] [Abstract][Full Text] [Related]
38. Lysophospholipid regulates release and activation of latent TGF-beta1 from chondrocyte extracellular matrix.
Gay I; Schwartz Z; Sylvia VL; Boyan BD
Biochim Biophys Acta; 2004 Aug; 1684(1-3):18-28. PubMed ID: 15450206
[TBL] [Abstract][Full Text] [Related]
39. Metalloproteinases in endochondral bone formation: appearance of tissue inhibitor-resistant metalloproteinases.
Mikuni-Takagaki Y; Cheng YS
Arch Biochem Biophys; 1987 Dec; 259(2):576-88. PubMed ID: 2447832
[TBL] [Abstract][Full Text] [Related]
40. Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis.
Martel-Pelletier J; McCollum R; Fujimoto N; Obata K; Cloutier JM; Pelletier JP
Lab Invest; 1994 Jun; 70(6):807-15. PubMed ID: 8015285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
